Generics Bulletin: All Contenthttps://insights.citeline.comSat, 04 Apr 2026 10:58:25 +0000en1hourly1 https://insights.citeline.com/generics-bulletin/policy-and-regulation/us-shields-generics-from-tariffs-amid-supply-chain-concerns-ODDONQOH7ZHQNHL7PU6L27WVLA/<![CDATA[US Shields Generics From Tariffs Amid Supply Chain Concerns]]>premium

      
]]> https://feeds.feedblitz.com/~/953169668/0/genericsbulletin~US-Shields-Generics-From-Tariffs-Amid-Supply-Chain-Concerns/https://insights.citeline.com/generics-bulletin/policy-and-regulation/us-shields-generics-from-tariffs-amid-supply-chain-concerns-ODDONQOH7ZHQNHL7PU6L27WVLA/
      
]]> Fri, 03 Apr 2026 12:30:27 +0000 https://insights.citeline.com/generics-bulletin/conferences/AAM/its-day-and-night-haruvi-on-how-the-aam-has-evolved-TYH3HIOGJFAFHBH6IG2VAPWY3I/<![CDATA[‘It’s Day And Night’ – Haruvi On How The AAM Has Evolved]]>premium

      
]]> https://feeds.feedblitz.com/~/953169671/0/genericsbulletin~%e2%80%98It%e2%80%99s-Day-And-Night%e2%80%99-%e2%80%93-Haruvi-On-How-The-AAM-Has-Evolved/https://insights.citeline.com/generics-bulletin/conferences/AAM/its-day-and-night-haruvi-on-how-the-aam-has-evolved-TYH3HIOGJFAFHBH6IG2VAPWY3I/
      
]]> Fri, 03 Apr 2026 12:20:34 +0000 https://insights.citeline.com/generics-bulletin/products/value-added-medicines/hyloris-warns-valacyclovir-launch-could-slip-into-2027-KTARLZEL4ZH7JBVUQ3NG35OUKA/<![CDATA[Hyloris Warns Valacyclovir Launch Could Slip Into 2027]]>premium

      
]]> https://feeds.feedblitz.com/~/953169674/0/genericsbulletin~Hyloris-Warns-Valacyclovir-Launch-Could-Slip-Into/https://insights.citeline.com/generics-bulletin/products/value-added-medicines/hyloris-warns-valacyclovir-launch-could-slip-into-2027-KTARLZEL4ZH7JBVUQ3NG35OUKA/
      
]]> Fri, 03 Apr 2026 12:20:20 +0000 https://insights.citeline.com/generics-bulletin/products/generics/gdufa-iv-us-fda-worries-about-revenue-shortfalls-industry-does-not-VMS7XAEE6JFOVFWAI2PDW66XKU/<![CDATA[GDUFA IV: US FDA Worries About Revenue Shortfalls, Industry Does Not ]]>premium

      
]]> https://feeds.feedblitz.com/~/953169677/0/genericsbulletin~GDUFA-IV-US-FDA-Worries-About-Revenue-Shortfalls-Industry-Does-Not/https://insights.citeline.com/generics-bulletin/products/generics/gdufa-iv-us-fda-worries-about-revenue-shortfalls-industry-does-not-VMS7XAEE6JFOVFWAI2PDW66XKU/
      
]]> Fri, 03 Apr 2026 12:19:53 +0000 https://insights.citeline.com/generics-bulletin/leadership/whos-hired-watson-returns-as-apotex-ceo-SNL3HKNCTJEPZCVCA3LS5N4GTY/<![CDATA[Who’s Hired? Watson Returns As Apotex CEO]]>premium

      
]]> https://feeds.feedblitz.com/~/953037614/0/genericsbulletin~Who%e2%80%99s-Hired-Watson-Returns-As-Apotex-CEO/https://insights.citeline.com/generics-bulletin/leadership/whos-hired-watson-returns-as-apotex-ceo-SNL3HKNCTJEPZCVCA3LS5N4GTY/
      
]]> Thu, 02 Apr 2026 11:11:59 +0000 https://insights.citeline.com/generics-bulletin/business/manufacturing/teva-clarifies-operations-stable-after-neot-hovav-strike-SCYVRJJGFRGJJETEG2UI2OE2EQ/<![CDATA[Teva Clarifies Operations Stable After Neot Hovav Strike]]>premium

      
]]> https://feeds.feedblitz.com/~/953036324/0/genericsbulletin~Teva-Clarifies-Operations-Stable-After-Neot-Hovav-Strike/https://insights.citeline.com/generics-bulletin/business/manufacturing/teva-clarifies-operations-stable-after-neot-hovav-strike-SCYVRJJGFRGJJETEG2UI2OE2EQ/
      
]]> Thu, 02 Apr 2026 10:50:39 +0000 https://insights.citeline.com/generics-bulletin/legalandip/amarin-insists-skinny-labels-are-not-a-safe-harbor-J7CXXPYDTRCWRH2SKSKB6X7NZY/<![CDATA[Amarin Insists Skinny Labels Are Not A Safe Harbor]]>premium

      
]]> https://feeds.feedblitz.com/~/953029289/0/genericsbulletin~Amarin-Insists-Skinny-Labels-Are-Not-A-Safe-Harbor/https://insights.citeline.com/generics-bulletin/legalandip/amarin-insists-skinny-labels-are-not-a-safe-harbor-J7CXXPYDTRCWRH2SKSKB6X7NZY/
      
]]> Thu, 02 Apr 2026 10:30:08 +0000